Atlas Trials

Dose Range-finding Study of ASP1585 in Chronic Kidney Disease Patients on Hemodialysis With Hyperphosphatemia

Clinical trial NCT02753894 · COMPLETED

Trial details

NCT number
NCT02753894
Sponsor
Astellas Pharma Inc
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Chronic Kidney Disease Patients on Hemodialysis With Hyperphosphatemia
Start date
2008-01-01
Primary completion
2008-06-01
Enrollment
73

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.